Determinants of the fluorescence emission spectrum of atheromatous plaques treated with haematoporphyrin in vitro
Studies were carried out on atheromatous plaques which had been incubated with the fluorescent dye haematoporphyrin. By varying the wavelength of excitation, it was possible to obtain fluorescence signals from different depths in plaque, since enhanced tissue penetration occurs when the wavelength of exciting light is increased. Moreover, the presence of ulcerated regions altered both excitation and emission spectra. These results suggest that corresponding measurements using laser/fibre-optic systems may be used to characterize plaques in vivo.
Key wordsFluorescence Plaques Haematoporphyrin Spectroscopy
Unable to display preview. Download preview PDF.
- 2.Hoyt CC, Richardds-Kortum RR, Costello B et al. Remote biomedical spectroscopic imaging of human artery wall.Lasers Surg Med 1988,8:1–9Google Scholar
- 3.Kittrell C, Willett RL, de Los Santos C et al. Diagnosis of fibrous arterial atherosclerosis using fluorescence.Appl Opt 1985,42:2280Google Scholar
- 8.Pollock ME, Eugene J, Hammer-Wilson M, Berns MW. Photosensitization of experimental atheromas by porphyrin.J Am Coll Cardiol 1987,9:629–46Google Scholar
- 14.Doiron D, Svaasand L, Profio AE. Light dosimetry in tissue: application to photoradiation therapy. In: Kessel D, Dougherty TJ (eds)Porphyrin Photosensitization. New York: Plenum Press 1983:63–76Google Scholar